LRCX — Lam Research Income Statement
0.000.00%
Last trade - 00:00
- $128.21bn
- $127.55bn
- $17.43bn
- 97
- 15
- 98
- 80
2019 June 30th | 2020 June 28th | 2021 June 27th | 2022 June 26th | 2023 June 25th | |
---|---|---|---|---|---|
Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,654 | 10,045 | 14,626 | 17,227 | 17,429 |
Cost of Revenue | |||||
Gross Profit | 4,358 | 4,609 | 6,805 | 7,872 | 7,855 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7,189 | 7,371 | 10,144 | 11,845 | 12,254 |
Operating Profit | 2,465 | 2,674 | 4,482 | 5,382 | 5,175 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,447 | 2,575 | 4,371 | 5,193 | 5,109 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,191 | 2,252 | 3,908 | 4,605 | 4,511 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,191 | 2,252 | 3,908 | 4,605 | 4,511 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,191 | 2,252 | 3,908 | 4,605 | 4,511 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 13.7 | 15.1 | 26.9 | 32.7 | 34 |
Dividends per Share |